메뉴 건너뛰기
The Lancet Oncology
Volumn 10, Issue 7, 2009, Pages 641-642
Are molecular neuroblastoma classifiers ready for prime time?
Author keywords

[No Author keywords available]
Indexed keywords

MYC PROTEIN; PROTEIN TYROSINE KINASE INHIBITOR; RNA;
EID: 67649306417     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70176-7     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 58249093955 scopus 로고    scopus 로고
    • The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report
    • Cohn S.L., Pearson A.D., London W.B., et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27 (2009) 289-297
    • (2009) J Clin Oncol , vol.27 , pp. 289-297
    • Cohn, S.L.1    Pearson, A.D.2    London, W.B.3
  • 2
    • 67649372693 scopus 로고    scopus 로고
    • Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
    • Vermeulen J., De Preter K., Naranjo A., et al. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study. Lancet Oncol 10 (2009) 663-671
    • (2009) Lancet Oncol , vol.10 , pp. 663-671
    • Vermeulen, J.1    De Preter, K.2    Naranjo, A.3
  • 3
    • 0033554684 scopus 로고    scopus 로고
    • Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
    • Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. N Engl J Med 341 (1999) 1165-1173
    • (1999) N Engl J Med , vol.341 , pp. 1165-1173
    • Matthay, K.K.1    Villablanca, J.G.2    Seeger, R.C.3
  • 4
    • 54049120220 scopus 로고    scopus 로고
    • Activating mutations in ALK provide a therapeutic target in neuroblastoma
    • George R.E., Sanda T., Hanna M., et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 455 (2008) 975-978
    • (2008) Nature , vol.455 , pp. 975-978
    • George, R.E.1    Sanda, T.2    Hanna, M.3
  • 5
    • 54049149961 scopus 로고    scopus 로고
    • Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
    • Janoueix-Lerosey I., Lequin D., Brugieres L., et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 455 (2008) 967-970
    • (2008) Nature , vol.455 , pp. 967-970
    • Janoueix-Lerosey, I.1    Lequin, D.2    Brugieres, L.3
  • 6
    • 54049094708 scopus 로고    scopus 로고
    • Identification of ALK as a major familial neuroblastoma predisposition gene
    • Mosse Y.P., Laudenslager M., Longo L., et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature 455 (2008) 930-935
    • (2008) Nature , vol.455 , pp. 930-935
    • Mosse, Y.P.1    Laudenslager, M.2    Longo, L.3
  • 7
    • 54049118823 scopus 로고    scopus 로고
    • Oncogenic mutations of ALK kinase in neuroblastoma
    • Chen Y., Takita J., Choi Y.L., et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 455 (2008) 971-974
    • (2008) Nature , vol.455 , pp. 971-974
    • Chen, Y.1    Takita, J.2    Choi, Y.L.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.